Page 2870 - Cote clinical veterinary advisor dogs and cats 4th

Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables. 1517

Bernese mountain dog (Continued) Biopsy (Continued) Bleeding diatheses (Continued)
steroid-responsive meningitis-arteritis in, 942 kidney rodenticide toxicosis and. See Anticoagulant
subaortic stenosis in, 948
in protein-losing nephropathy, 830.e3
rodenticides
VetBooks.ir tremors in, 661 liver Bleeding disorders, 1202
in Shar-pei fever, 908.e2
tremors/myoclonus in, 994
Bleeding patient, initial approach to, 1403.e2a
von Willebrand disease in, 1043
Bleeding time. See Buccal mucosal bleeding time
in cirrhotic/fibrosing liver disease, 175
Beta-adrenergic blocking agents. See also specific drugs
Bleomycin, 1465
in superficial necrolytic dermatitis, 952
for arrhythmias, 159–160 laparoscopic, 1128–1129 Blenoxane. See Bleomycin
for atrial fibrillation, 95–96 lung, 554 Blepharitis, 870–871
for atrial tachycardia, 98 muscle, 1134.e1–1134.e2, 1134.e1f Blepharospasm, 201
for canine post-traumatic stress disorder, 744 nasal, 680 Blindness, 123–125
for chronic heart failure, 411 nerve, 1134.e1 acute, 1202.e3
for pheochromocytoma, 786 in nodular skin disorders, 695 central, 123–125, 124f
for post-traumatic stress disorder, 744 prostatic, 1153–1155 Bloat. See Gastric dilation/volvulus (GDV)
for subaortic stenosis, 949 skin Block vertebrae, 933.e2
for tetralogy of Fallot, 966 in pinnal disease, 790 Blockage (urinary tract), relief of, 1175–1176
Beta-blockers. See Beta-adrenergic blocking agents procedure for, 1093 Blood
Beta-cell tumor. See Insulinoma in superficial necrolytic dermatitis, 952 administration of, 1171. See also Transfusion therapy
Betamethasone, 1510.e7t synovial, 889 blood-borne pathogen screening, 1172.e2t–1172.e3t
Betapace. See Sotalol ultrasound-guided percutaneous, 1064–1065, 1065f collection of, for transfusion, 1169–1172
Betasone. See Betamethasone Biosol. See Neomycin in urine. See Hematuria
Betaxolol, for glaucoma, 388 Bioterrorism agents, 790.e3–790.e5 Blood-borne pathogens, 1172.e2t–1172.e3t
Bethanechol Birman cat Blood cross-matching, 1084–1085, 1085f, 1330
administration and dosage of, 1465 alopecia in, 46f Blood culture, in infective endocarditis, 295
for feline lower urinary tract signs, 333t cataracts in, 147 Blood dyscrasias, phenobarbital and, 783.e3
for reflex dyssynergia, 872 neonatal losses in, 687 Blood gas analysis, 1065.e1–1065.e2, 1315
for urinary bladder atony/hypotonia, 91 Birth canal, 279–280 in pulmonary thromboembolism, 843
Bezoar, 141 Bisacodyl, 1465 Blood glucose curve, 1119–1120
BHFD. See Black hair follicular dysplasia (BHFD) Bismuth subsalicylate Blood loss anemia, 57–58
Biaxin. See Clarithromycin administration and dosage of, 1465 Blood pH, 1315–1316
Bicarbonate. See also Sodium bicarbonate for flatulence, 342 Blood pressure
acidosis treated with, 15.e3 Bisphosphonates, for osteogenesis imperfecta, 724.e2 decreased. See Systemic hypotension
alkalosis treated with, 44.e4 Bitch increased. See Systemic hypertension
blood, 1312 abortion in, 2–3 measurement of, 1065–1067, 1066f. See also Central
Bicavitary effusions, 1220 breeding management of, 130.e2–130.e4, venous pressure monitoring
Biceps tendinopathy, 914 130.e3f–130.e4f Blood products administration. See Transfusion therapy
Biceps tendon release, 915 breeding soundness exam, 1070–1071 Blood sampling, arterial. See Arterial blood sampling
Biceps tenosynovitis, 914 deworming of, 894.e3 Blood sugar. See Glucose, blood
Bichon frisé diagnostic approach to, 1396a Blood transfusion. See Transfusion therapy
cataracts in, 147 eclampsia in, 281–282 Blood types
diabetes mellitus in, 253.e2 gestation length in, 816 in cats, 686, 1203
immune-mediated hemolytic anemia in, 60 infertility in. See Infertility in dogs, 1204
nephrolithiasis in, 689 lactation disorders in, 570–571 Blood typing, 1084–1085, 1316
paroxysmal dyskinesia in, 661 neonatal loss prevention strategies in, 689 Blood urea nitrogen (BUN), 1317
pemphigus foliaceus in, 769f postpartum management of, 1151–1153, 1152f elevation with isosthenuria but preserved renal
postrabies vaccination panniculitis and alopecia in, 47f pregnancy in, 2–3, 816–818, 817f function, 1317
pyoderma in, 851 prolonged estrus in, 822–823, 822.e1f Blood vessel defects, 433
rabies vaccine-induced vasculitis, 1031 pseudocyesis in, 831–832 Blood volume, decreased circulating. See Dehydration
urolithiasis in, 1014, 1014.e2, 1016 pyometra in, 853–856, 854.e2f Bloodhound
vasculitis in, 1031.e4 subinvolution of placental sites in, 950–951, 951f, ectropion in, 296
Bidi cigarettes, 693.e3 951.e1f trichiasis in, 273
Big dog–little dog, 120.e2 vaginal congenital abnormalities in, 1027–1028, 1027f ventricular septal defect in, 1036
Biguanides, 1217.e1 whelping in. See Dystocia; Parturition Blowflies, 674
Bile acids Bite cells. See Eccentrocytes Blue-green algae toxicosis, 125.e2–125.e3, 442
blood and urine levels of, 1312–1313 Bite wounds, 120.e2–120.e3. See also Cat bite abscess; Blue tick coonhound, perianal gland hyperplasia in,
in cirrhotic/fibrosing liver disease, 175 Shearing/degloving wounds 771.e2
Bile duct adenoma. See Hepatobiliary cystadenoma Bitter orange, 463t–464t Bluetongue virus, and abortion, 2
Bile duct obstruction Biurate urolithiasis. See Urate/biurate urolithiasis Body cavity fluid analysis, 1343–1344
extrahepatic, 118–119, 119f Black beauties. See Amphetamine toxicosis Body condition score, 140.e1
pancreatitis and, 740, 743 Black hair follicular dysplasia (BHFD), 344 Body surface area, 611t
Bile peritonitis, 119.e2 Black-legged tick, 978.e2 Body wall disorders, and dyspnea, 1219
Biliary adenoma, 446 Black Russian terrier, laryngeal paralysis–polyneuropathy Body weight–to–body surface area, 608t
Biliary carcinoma, 446 complex in, 808 BOGS. See Bacterial overgrowth syndrome
Biliary cystadenoma, 446. See also Hepatobiliary Black skin disease of Pomeranians. See Alopecia X Bone
cystadenoma Black widow spider, 928–929 aspiration of, 1067–1068
Biliary tract Bladder. See Gallbladder; Urinary bladder biopsy of, 1067–1068
anatomy of, 119f Bladder atony. See Atonic urinary bladder congenital diseases of, 1204
extrahepatic obstruction of, 118–119, 119f Bladder infection, 232. See also Urinary bladder neoplasia of, primary, 1204.e2. See also specific tumors
malignant neoplasia of, 446–448 Bladder overdistention. See Atonic urinary bladder radiation therapy adverse reactions in, 863.e3
pancreatitis and, 743 Blade. See Amphetamine toxicosis Bone grafting, 1068.e2
Bilious vomiting syndrome, 119–120 Blalock-Taussig shunt, modified, 966 Bone infarction, 725
Bilirubin, 1313. See also Hyperbilirubinemia Blast crisis, 588 Bone marrow aspiration/core biopsy, 1068–1070,
Bilirubin crystals, 1290, 1332f Blastomyces dermatitidis, 121–123, 122f 1070.e1f
Bilirubinuria, 1314 Blastomyces testing, 1314–1315, 1315.e1f Bone marrow biopsy, 1070.e1f
in hepatic lipidosis, 445 Blastomycosis, 121–123, 122f, 725 Bone marrow disorders, 1204.e1
urine discoloration and, 266.e6 panniculitis and, 747 Bone marrow examination
Bilobed gallbladder, 119.e2 serologic testing for, 1314–1315 in acute leukemia, 587
Bimatoprost, 389, 846–847 Bleach cytology, 587, 1317–1318
Bio-Cox. See Salinomycin description of, 1217.e1 in myelodysplasia, 672
Biofilm, 725 toxicosis caused by, 13–15, 178–179 Bonine. See Meclizine
Biologically appropriate raw food (BARF), 863 Blebs, pulmonary, 834–835 Borax. See Boric acid toxicosis
Biopsy Bleeding diatheses, 431. See also Hemostatic defects Borborygmi, 256, 341–342
bone, 1067–1068, 1068–1070, 1070.e1f classification of, 433 Border collie. See also Collie
bone marrow, 1068–1070, 1070.e1f hemorrhage and, 433 aggression in, 40
conjunctival, 961.e2 hemostatic tests for. See Coagulation profile anxiety problems in, 324
www.ExpertConsult.com